ABATACEPT CONFERS CLINICAL EFFICACY REGARDLESS OF BASELINE CRP STATUS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE IN THE AIM TRIAL

被引：0

作者：

Sibilia, Jean ^{[1
]}

Flipo, Rene Marc ^{[2
]}

Combe, Bernard ^{[3
]}

Gaillez, Corine ^{[4
]}

Le Bars, Manuela ^{[4
]}

Poncet, Coralie ^{[5
]}

Elegbe, Ayanbola ^{[6
]}

Westhovens, Rene ^{[7
]}

机构：

[1] Univ Strasbourg, Dept Rheumatol, Strasbourg, France

[2] Ctr Hosp Univ France, Dept Rheumatol, Lille, France

[3] Hop Lapeyronie, Montpellier, France

[4] Bristol Myers Squibb Co, Med Affairs, Rueil Malmaison, France

[5] Docs Int, Dept Biostat, Sevres, France

[6] Bristol Myers Squibb Co, Global Biometr Sci, Princeton, NJ USA

[7] Univ Hosp Gasthuisberg, Dept Rheumatol, Louvain, Belgium

来源：

RHEUMATOLOGY | 2012年 / 51卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：124 / 125

页数：2

共 50 条

[41] Long-term efficacy of abatacept through 2 years of treatment in rheumatoid arthritis patients in the aim trial [J].

Kremer, J. ;

Russell, A. ;

Westhovens, R. .

JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) :1630-1630

[42] The efficacy and safety of abatacept in patients with active rheumatoid arthritis and an inadequate response to anti-TNF therapy: Results from the arrive trial [J].

Emery, P. ;

Pritchard, C. ;

Zhou, X. ;

Genovese, M. ;

Schiff, M. .

RHEUMATOLOGY, 2008, 47 :II45-II45

[43] Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial [J].

Combe, Bernard ;

Kivitz, Alan ;

Tanaka, Yoshiya ;

van der Heijde, Desiree ;

Simon, J. Abraham ;

Baraf, Herbert S. B. ;

Kumar, Uma ;

Matzkies, Franziska ;

Bartok, Beatrix ;

Ye, Lei ;

Guo, Ying ;

Tasset, Chantal ;

Sundy, John S. ;

Jahreis, Angelika ;

Genovese, Mark C. ;

Mozaffarian, Neelufar ;

Landewe, Robert B. M. ;

Bae, Sang-Cheol ;

Keystone, Edward C. ;

Nash, Peter .

ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (07) :848-858

[44] IMPACT OF CONCOMITANT METHOTREXATE ON THE ENHANCED CLINICAL EFFICACY OF ABATACEPT AFTER 24 WEEKS IN RHEUMATOID ARTHRITIS PATIENTS [J].

Takahashi, N. ;

Kojima, T. ;

Funahashi, K. ;

Hanabayashi, M. ;

Hirabara, S. ;

Asai, S. ;

Ishiguro, N. .

ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 :680-680

[45] Impact of Concomitant Methotrexate on the Enhanced Clinical Efficacy of Abatacept after 24 Weeks in Rheumatoid Arthritis Patients [J].

Takahashi, Nobunori ;

Kojima, Toshihisa ;

Hirano, Yuji ;

Kanayama, Yasuhide ;

Funahashi, Koji ;

Ishiguro, Naoki .

ARTHRITIS & RHEUMATOLOGY, 2014, 66 :S1094-S1095

[46] Long-term safety and efficacy of treatment with subcutaneous abatacept in Japanese patients with rheumatoid arthritis who are methotrexate inadequate responders [J].

Amano, Koichi ;

Matsubara, Tsukasa ;

Tanaka, Takaaki ;

Inoue, Hiroshi ;

Iwahashi, Mitsuhiro ;

Kanamono, Toshihisa ;

Nakano, Teruaki ;

Uchimura, Shoichi ;

Izumihara, Tomomaro ;

Yamazaki, Akira ;

Karyekar, Chetan S. ;

Takeuchi, Tsutomu .

MODERN RHEUMATOLOGY, 2015, 25 (05) :665-671

[47] Abatacept or infliximab for patients with rheumatoid arthritis and inadequate response to methotrexate: an Italian trial-based and real-life cost-consequence analysis [J].

Benucci, M. ;

Stam, W. B. ;

Gilloteau, I. ;

Sennfaelt, K. ;

Leclerc, A. ;

Maetzel, A. ;

Lucioni, C. .

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (04) :575-583

[48] Abatacept sustains inhibition of radiographic progression over 2 years in rheumatoid arthritis (RA) patients with an inadequate response to methotrexate (MTX): Results from the long-term extension (LTE) of the AIM trial [J].

Genant, H. K. ;

Peterfy, C. ;

Westhovens, R. ;

Becker, J. P. ;

Aranda, R. ;

Teng, J. ;

Kremer, J. M. .

ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 :57-58

[49] Sustained clinical efficacy demonstrated by the selective co-stimulation modulator abatacept (CTLA41g) in combination with methotrexate at 2 years in rheumatoid arthritis patients with an inadequate response to methotrexate. [J].

Kremer, J ;

Shergy, W ;

Tindall, E ;

Aranda, R ;

Nuamah, I ;

Zhou, Y ;

Becker, JC .

ARTHRITIS AND RHEUMATISM, 2004, 50 (09) :S182-S182

[50] Efficacy of abatacept or infliximab treatment in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a 1-year double-blind, randomized, placebo-controlled trial [J].

Bessette, L. ;

Homik, J. ;

Dougados, M. ;

Keiserman, M. ;

Codding, C. ;

Songcharoen, S. ;

Berman, A. ;

Nayiager, S. ;

Saldate, C. ;

Aranda, R. ;

Becker, J. ;

Li, T. ;

Lin, C. ;

Cornet, P. L. N. ;

Schiff, M. .

JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) :1178-1179

← 1 2 3 4 5 →